]i transients and contractions. Once Gi is activated by muscarinic agonist, the ␣ i-subunit is released from the ␤␥-subunits, but it is silent, and its inhibition of the AC/cAMP cascade, manifested by I Ca reduction, is not seen unless AC has been previously activated. In colchicine-treated cells, CCh caused greater reductions of [Ca 2ϩ ]i transients and contractions than in untreated cells. The ␣i-subunit became effective in signaling through the AC/cAMP cascade and reduced ICa without changing its voltage-dependence. Isoproterenol (Iso) regained its efficacy and reversed ICa inhibition by CCh. Stimulation of I Ca by forskolin persisted in colchicine-treated cells when Iso was ineffective. The effect of CCh on IK(ACh) was occluded in colchicine-treated cells. Colchicine treatment, per se, may increase I K(ACh) by ␤␥-subunits released from Gs to mask this effect of CCh. Microtubules suppress I Ca regulation by ␣i; their disruption releases restraints that unmask muscarinic inhibition of I Ca. Summarily, colchicine treatment reverses regulation of ventricular excitation-contraction coupling by autonomic agents.
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cytoskeleton; excitation-contraction coupling; colchicine MICROTUBULES OF THE CYTOSKELETON modulate signal transduction for a variety of extracellular ligands in addition to regulating cell form, motility, and division (reviewed in Ref. 13 ). According to the GTP cap model, tubulin subunits that comprise microtubules are stabilized, because nonexchangeable GTP is bound at the end or cap. Microtubules depolymerize when the cap is removed and GDP-tubulin is exposed. Guanine nucleotide exchange serves not only to regulate tubulin stability but also to modulate the activity of guanine nucleotide binding proteins. In the polymerized state, exchangeable GTP is positioned at the interface between tubulin dimers and is thus protected and unavailable for exchange. When depolymerized by agents such as colchicine, exchangeable GTP becomes available for modulating signal transduction.
This laboratory reported that, when colchicine had disrupted microtubule structure, the L-type Ca 2ϩ current (I Ca ) and intracellular Ca 2ϩ transients increased (9) . The results of colchicine treatment were similar to those of the ␤-adrenoceptor agonist isoproterenol (Iso), whose stimulation of I Ca and of intracellular Ca 2ϩ transients was blunted in colchicine-treated myocytes. The adenylyl cyclase (AC) inhibitor, 2Ј-deoxyadenosine 3Ј-monophosphate (2Јd3Ј-AMP), prevented the increase of I Ca by colchicine. It was concluded that free tubulin (tubulin dimer) transferred exchangeable GTP to the stimulatory guanine nucleotide binding protein, G s , to activate AC (see also Ref. 25) . Washout of colchicine reversed its effects (14) . In intact cells, microtubule disruption by colchicine-modulated Ca 2ϩ sparks characteristics (14) .
In cardiac myocytes, microtubule disruption could potentially result in activation of other G proteins, by making GTP available, such as the inhibitory guanine nucleotide binding protein G i (22) . In particular, the action of muscarinic receptor (mAChR) agonists mediated by the inhibitory guanine nucleotide binding protein G i may also be modulated by the cytoskeleton (22) . In visceral smooth muscle, carbachol inhibits barium current (I Ba ) and colchicine increased the amplitude of I Ba and selectively blocked its inhibition by carbachol (21) .
Here we analyzed whether muscarinic effects are altered in rat ventricular myocytes by microtubule disruption with colchicine. This cell preparation has several advantages. Muscarinic agonist decreases contractions by activating ACh-activated K ϩ current [I K(ACh) ] (17). The ␤␥-subunits from G i are able to activate inwardly rectifying K ϩ channels [I K(ACh) ]. The ␣ i -subunit is selective for inhibition of cardiac AC (20) , yet muscarinic agonist is not reported to suppress I Ca . Our approach allowed a systematic examination of how colchicine reciprocally modulated autonomic signaling by ␤-adrenoceptors and mAChRs in a single cardiac cell type. A preliminary account of our findings has been presented in abstract form (10) .
MATERIALS AND METHODS
Cell preparation. Ventricular myocytes were isolated from the hearts of anaesthetized (pentobarbital sodium, 100 mg/kg ip) male Wistar rats (300 g) as described elsewhere (16) . After isolation, cells were kept at room temperature (24 -25°C) ]i) transients and associated contractions were recorded in intact myocytes. Cells were incubated in fluo 3-AM (1-3 M) for 20 min and then placed in Tyrode solution for at least 20 min to allow intracellular esterases to deesterify the dye. Myocytes were then placed in an inverted microscope in a chamber that had platinum electrodes parallel to its long axis to field stimulate the cells. Stimuli (1-to 2-ms duration, voltage at 1.2ϫ threshold) were applied at a frequency of 1 Hz. During experiments, myocytes were superfused with a Tyrode solution of the same composition than the one used to record I K(ACh) (see above).
Images from fluo 3-loaded myocytes were obtained with a laser scanning confocal microscope (Zeiss 510 LSM), attached to an inverted microscope fitted with a water-immersion objective (ϫ63, 1.2 numerical aperture). Fluo 3 fluorescence was excited at a wavelength of 488-nm by an argon ion laser. Fluorescence emission was measured at wavelengths of Ն505 nm. Images were acquired in line-scan mode. A single myocyte was repetitively scanned along a line parallel to the longitudinal cell axis every 1.5 ms. Because the line of scan was parallel to the longitudinal axis, the length of the cell could be measured to calculate the percentage of cell shortening from the confocal image. Each image was processed and analyzed with the background subtracted using the TDL (Research System) program. ]rest is initial intracellular Ca 2ϩ taken as 125 nM and Kd is the dissociation constant (400 nM) for Ca 2ϩ and fluo 3. To verify the microtubule disruption in our conditions, control and colchicine-treated myocytes were fixed and immunolabeled with anti ␤-tubulin as previously detailed (14) . Images were recorded in the same microscope by using 2-photon excitation delivered by a Ti-Sa laser (Coherent) at 800 nm. Emission was collected at Ͼ505 nm after filtering infrared light. Three-dimensional reconstructions were made with Imaris (Bitplane AG).
All experiments were performed at room temperature. Data analysis and statistics. Data are reported as means Ϯ SE. Student's t-test for paired and unpaired samples was used as appropriate. P Յ 0.05 was regarded statistically significant. Figure 1A shows representative examples of line-scan images recorded in a control rat cardiac myocyte before and during 1 M carbachol (CCh) application. Data obtained in a myocyte, where microtubules had been disrupted by colchicine treatment, are shown. The intensity of [Ca 2ϩ ] i fluorescence was higher in the colchicinetreated cell, and fluorescence intensity decreased in CCh. Pooled data are shown in Fig. 1B . In control conditions, field stimulation at 1 Hz evoked [Ca 2ϩ ] i transients that averaged 458 Ϯ 31 nM (n ϭ 16). At this peak [Ca 2ϩ ] i (Fig. 1B) , cell shortening averaged 14.2 Ϯ 1.0% of resting cell length. When 1 M CCh was added, peak [Ca 2ϩ ] i declined by 8% to 421 Ϯ 34 nM (P Ͻ 0.03) and cell shortening diminished by 11% to 12.6 Ϯ 0.7% of cell length (P Ͻ 0.001). The reduced cell shortening by muscarinic agonist is consistent with the observations of other studies (17) in rat ventricular myocytes. In 13 myocytes treated with colchicine (1 M), peak [Ca 2ϩ ] i reached 569 Ϯ 35 nM and cell shortening averaged 15.6 Ϯ 1.4% of resting cell length (Fig. 1B) . The peak [Ca 2ϩ ] i was significantly greater in colchicine-treated cells (P Ͻ 0.02), but cell shortening did not reach statistical significance. At 1 M, CCh reduced peak [Ca 2ϩ ] i by 17% to 471 Ϯ 24 nM (P Ͻ 0.001) and cell shortening by 22% to 12.2 Ϯ 1.4% (P Ͻ 0.001) of resting cell length. The effects of CCh on peak [Ca 2ϩ ] i (P ϭ 0.004) and cell shortening (P ϭ 0.01) were greater in colchicine-treated myocytes. The peak [Ca 2ϩ ] i in the presence of CCh did not differ between untreated and colchicine-treated myocytes (P ϭ 0.27).
RESULTS

Peak [Ca 2ϩ ] i and cell shortening.
L-type calcium current. Muscarinic agonists per se do not significantly affect I Ca in mammalian ventricular myocytes until cAMP has been raised by, for example, ␤-adrenoceptor agonist (accentuated antagonism, Ref. 15). We tested the possible effect of CCh in control myocytes at a higher concentration (10 M) to ascertain whether muscarinic stimulation can induce some inhibition of the I Ca . Figure 2A shows sample traces of I Ca of a control myocyte before and during CCh perfusion and in the presence of the ␤-agonist Iso. The changes in I Ca are plotted as a function of time. CCh slightly decreased I Ca by ϳ20%, which could be due to the basal AC activity. Further application of Iso almost doubled the initial I Ca , because it is characteristic of ␤-adrenergic stimulation. However, the larger-than-normal I Ca recorded in colchicine-treated myocytes was markedly reduced by 10 M CCh (Fig. 2B) . Peak I Ca decreased to Ϫ10 pA/pF after the 3-min CCh addition. Applying Iso (1 M) in the presence of CCh largely restored I Ca to its original amplitude of Ϫ14 pA/pF. The variations of I Ca by CCh and Iso applications in this colchicine-treated cell are shown in Fig. 2B . CCh was more effective in decreasing I Ca in the colchicine-treated myocyte, and application of Iso restored the reduced I Ca up to, but not over, the original value before CCh. The average of such experiments in colchicine-treated cells is shown in Fig. 3 . Application of Iso alone had no effect on peak I Ca density, a finding reported previously (9) . CCh, per se, inhibited I Ca by up to 50% in these cells, an effect reversed by the subsequent addition of Iso (Fig. 3) . Thus the actions of these agonists appeared to be reversed in colchicine.
Is AC activity maximal in colchicine-treated myocytes? Failure of Iso per se to increase I Ca (9) and to raise I Ca above initial value when added on top of CCh on colchicine-treated cells (Figs. 2 and 3 ) could arise if AC activity is maximal. Therefore, we also tested forskolin, which in contrast to Iso, directly activates AC. In untreated cells (n ϭ 5), 10 M forskolin increased I Ca to ϳ2.3-fold of initial values (Fig. 4A) . Peak I Ca shifted from 0 mV to Ϫ10 mV. As reported previously (9), treatment with colchicine alone augmented I Ca (Fig.  4B) . The addition of forskolin also increased I Ca in colchicinetreated myocytes (n ϭ 6). Peak current increased again to 2.3-fold of initial values when forskolin was applied. Thus the signal function of Iso to AC is occluded not because the enzyme activity is maximal but most likely because ␣,␤-tubulin donates GTP to G s .
The unmasking of muscarinic inhibition of I Ca by colchicine treatment indicates a qualitative change in signal transduction. However, this may not be the only signal component to change in colchicine. ACh reduced contraction force in rat ventricular myocytes by activating I K(ACh) . We examined this variable to ascertain whether quantitative changes in it participated in the greater effect of colchicine on peak [Ca 2ϩ ] i and cell shortening.
I K(ACh) . In these experiments, 3-s voltage ramps from Ϫ100 to ϩ20 mV were applied; the current-voltage relation displayed inward rectification (Fig. 5, A and B) . CCh (1 M) was added, and the voltage ramp was applied within 5-10 s after a change in holding current was detected. In this cell, the membrane hyperpolarized by ϳ2 mV and membrane current shifted inward at Ϫ100 mV. In the absence of colchicine membrane current was Ϫ11.8 Ϯ 1.2 pA/pF at Ϫ100 mV when normalized to cell capacitance (Fig. 5A ). CCh shifted current inward by Ϫ0.6 Ϯ 0.1 pA/pF (n ϭ 10) at Ϫ100 mV (Fig. 5C) . These results indicate the expected activation of inwardly rectifying I K(ACh) by CCh (17) . As the exposure to CCh continued, I K(ACh) declined because of desensitization. In colchicine-treated cells, initial membrane current was Ϫ14.3 Ϯ 2.2 pA/pF at Ϫ100 mV and 3.8 Ϯ 0.4 at ϩ20 mV. These currents were slightly but not significantly greater than those in untreated cells (P Ͼ 0.10). However, CCh failed to induce an inward current [change in current was ϩ0.7 Ϯ 0.62 pA/pF (n ϭ 5) at Ϫ100 mV] (Fig. 5D) . Results indicate that, whereas muscarinic agonist induced I K(ACh) in normal cardiac myocytes, it did not activate I K(ACh) in colchicine-treated cells.
DISCUSSION
Microtubule disruption by colchicine augments muscarinic inhibition of excitation-contraction coupling in rat ventricular myocytes. CCh reduced the magnitude of intracellular Ca 2ϩ transients and cell shortening more when microtubules had been disrupted. Colchicine treatment unmasks muscarinic inhibition of I Ca , and this can largely account for the greater suppression of Ca 2ϩ transients and contractions. On the contrary, colchicine treatment occludes I K(ACh) activation by CCh. Also, microtubule disruption interferes with ␤-adrenoceptor regulation of excitation-contraction coupling (9, 14) . Thus microtubule depolymerization unmasks muscarinic signaling to L-type Ca 2ϩ channels and masks muscarinic signaling to I K(ACh) in rat ventricular myocytes. The proposed mechanisms of action are described in Fig. 6 in the untreated state, with the microtubule cytoskeleton intact (2-photon 3-D image reconstruction) and in the presence of colchicine, with all microtubules depolymerized. Agonist occupancy of muscarinic and ␤ 1 -adrenoceptors would promote dissociation of heterotrimeric G proteins via guanine nucleotide exchange (GTP replaces GDP). In untreated cells, Iso occupies ␤ 1 -adrenoceptors and stimulates I Ca through the ␣ s /AC/cAMP cascade, and CCh occupies mAChR and activates I K(ACh) through ␤␥-subunits. CCh does not inhibit I Ca until Iso has acted. In colchicinetreated cells, ␣,␤-tubulin dimers would donate GTP to ␣ ssubunit to activate the AC/cAMP cascade and increase I Ca . Now, ␣ i -subunit is no longer "silent" and inhibits the AC pathway to I Ca . ␤␥-subunits from G s would have already activated (and desensitized) I K(ACh) to occlude its activation by 
where Vrev is the reversal potential, V0.5 is the potential of demiactivation, and Dx is the slope factor of the activation curve (2). *P Ͻ 0.05, **P Ͻ 0.005. CCh. Not shown in the figure is the action of forskolin, which bypasses G s protein to stimulate AC directly and increase I Ca .
In addition to their structural function, microtubules are G protein like and are GTP donors when tubulin dimers form in colchicine (18) . In rat ventricular myocytes, colchicine mimics the effects of ␤-adrenoceptor agonist Iso to increase I Ca and intracellular Ca 2ϩ transients and to reduce Ca 2ϩ spark amplitude (9, 14) . It was proposed that ␣,␤-tubulin dimers donated GTP to the stimulatory guanine nucleotide-binding G s protein and stimulated AC. The results were consistent with AC/PKAdependent phosphorylation of proteins that are also the target of Iso whose effects were blunted in the presence of colchicine (14) . Treatment of guinea pig ventricular myocytes with colchicine increased basal cAMP content and markedly reduced the ability of Iso to increase both cAMP formation and I Ca (16) .
Forskolin, which directly activates AC, retains its ability to increase I Ca by the same proportion in the absence and presence of colchicine. This indicates that AC sensitivity to stim- Fig. 5 . CCH is unable to activate an inward current in colchicine-treated myocytes. A: currents elicited from Ϫ100 to Ϫ60 mV in a control myocyte before (black trace) and during (gray trace) 1 M CCh application. Membrane current became more inward at Ϫ100 mV. The result indicates the expected activation of inwardly rectifying IK(ACh) by CCh. The zero current potential was Ϫ72.77 mV before CCH and Ϫ73.08 during CCH application. B: the same in a colchicine-treated cell. No inward current was activated by CCh. Membrane current changes induced by CCh at Ϫ100 (white bars) and ϩ20 mV (gray bars) in control (C; n ϭ 10) and in colchicine (D; n ϭ 5). *P Ͻ 0.05. ulation is unchanged and points to a target proximal to AC as the site for diminished Iso effect. By donating GTP to G s , ␣,␤-tubulin dimers activate AC via G s . Type V AC, which is found in the heart, is activated synergistically by forskolin and ␣ s -subunits but additively by Iso and ␣ s -subunits (reviewed in Ref. 20) . Therefore, the ability of ␣ s -GTP arising from agonist occupancy of ␤-adrenoceptors to stimulate AC activity should be diminished in colchicine-treated myocytes (16) . The net effect is to occlude stimulation of I Ca by Iso (Refs. 9, 14, and present report). Dissociated G s would also reduce ␤-adrenoceptor affinity for agonist (7) . In adrenal cortical cells treated with colchicine, forskolin continued to stimulate AC, whereas ACTH, which acts through ␣ s -subunit, no longer did so (6) .
Muscarinic agonists minimally inhibit I Ca in rat ventricular myocytes unless AC has been previously activated (17) . Cardiac isoforms of AC, types V and VI, are inhibited by ␣ i -but not by ␤␥-subunits (20) . There is no evidence for negative regulation of I Ca by ␤␥-subunits in rat ventricular myocytes in contrast to results when L-type Ca 2ϩ channels are expressed in Xenopus oocytes (12) . The lack of ␣ i -GTP signaling could arise from inaccessibility of ␣ i -GTP or insufficient AC activity. Colchicine, either by preventing sequestration of ␣ i -subunits or by activating AC through ␣ s -GTP, could remove restraints on this component of muscarinic signaling. We favor the view that by releasing ␣,␤-tubulin dimers, colchicine stimulates AC and therefore reveals muscarinic inhibition of I Ca . Muscarinic inhibition of I Ca in colchicine-treated myocytes conforms to "accentuated antagonism," because inhibition requires the prior stimulation of AC (15) . When ␣ i -GTP is present, AC is inhibited and thus the cAMP/PKA phosphorylation cascade. Conceivably, ␣,␤-tubulin dimers could also donate GTP to the ␣-subunit of the inhibitory guanine nucleotide binding protein, G i (18) . In rat ventricular myocytes, the evidence indicates that microtubule disruption leads to activation of G s but not of G i . This specificity could be explained by the presence of a spatial restriction or compartment between microtubules and G s .
Colchicine inhibits binding to and activation of mAChR by antilaminin I g G (1). Our results indicate that colchicine did not impede activation of mAChR by CCh, because I Ca inhibition by CCh was unmasked in colchicine-treated myocytes and suppression of [Ca 2ϩ ] i transients and contractions was greater. CCh, like ACh (17), reduces cell shortening in untreated rat ventricular myocytes. This is ascribed to a briefer action potential duration by I K(ACh) activation. These ligand-gated K ϩ channels are present in ventricle at lower density than in atrium. Rat ventricular myocytes have m 2 AChR and K (ACh) channels with the former in greater abundance (5) . The m 2 AChR is located primarily on the cell surface and much less so in T-tubules. In contrast, the proteins that comprise K (ACh) channels (Kir3.1 and Kir3.4) are found in T-tubules. Activation of I K(ACh) in ventricular myocytes, as in atrial myocytes, presumably arises from the action of ␤␥-subunits (24) . Therefore, muscarinic signaling in myocytes with intact microtubules already involves one component of heterotrimeric G i . The failure to inhibit I Ca under these conditions cannot be readily explained by a lack of ␣ i -GTP but rather by its inefficient signaling through AC.
The addition of CCh produces two signaling moieties, because heterotrimeric G i dissociates into ␣-and ␤␥-subunits in the presence of GTP. Why is the effect of CCh on I K(ACh) not increased when colchicine disrupts microtubules? Colchicine, by releasing ␣,␤-tubulin dimers, may have already activated I K(ACh) through ␤␥-subunits that dissociate from G s . Thus I K(ACh) activation by CCh could be occluded. ␤␥-subunits lack specificity and there is little distinction between them for this signal pathway (23) .
How selective is colchicine action? Class C L-type Ca 2ϩ channels have an A kinase anchoring protein, microtubuleassociated protein 2B (MAP2B), that binds to the ␣ 1 -subunit (4). However, these L-type Ca 2ϩ channels do not bind tubulin, and microtubule disruption had no effect on MAP2B association with the channel. Cytochalasins B and D prevent actin polymerization, displace G i , and impede muscarinic signaling to L-type Ca 2ϩ channels and K ACh channels in embryonic stem cells (3) . Cytochalasin D, unlike colchicine, reduced I Ca but did not prevent Iso from stimulating this current (19) . Therefore, microtubule disruption by colchicine does not need to involve a direct action on the Ca channel, a redistribution of G i , or depolymerization of the actin component of the cytoskeleton. Paclitaxel, a microtubule stabilizer, had no effect on I Ca in rat ventricular myocytes (9) or on cAMP and I Ca in guinea pig ventricular myocytes (11, 16) . Whereas the effects of Iso on cAMP and I Ca were unchanged in paclitaxel, it opposed muscarinic agonist action on these variables (16) .
In summary, microtubule disruption with colchicine reverses the pattern of autonomic signaling in cardiac myocytes. When soluble tubulin is increased, muscarinic agonist is enabled to inhibit I Ca , whereas ␤-adrenoceptor agonist is disabled from doing so. The reversal of autonomic agonist action can be accounted for by the donation of GTP from soluble tubulin to the ␣-subunit of G s as well as the ␤␥-subunit to I K(ACh) . The cytoskeleton is viewed as integrating convergent signal pathways in space and time (13) . This concept is well illustrated by the dynamic interplay of tubulin and tubulin dimers on the reactivity of the heart to muscarinic and adrenergic agonists.
